Current Assets

Operating Lease Income - 2025 (Lessor)

Neurocrine Biosciences Operating Lease Income - 2025 (Lessor) remained flat by 0.0% to $3.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $3.50M to $3.50M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryProfitability
SignalHigher is better
VolatilityStable
First reportedQ3 2023
Last reportedQ1 2026May 5, 2026

How to read this metric

Higher values indicate a robust and stable pipeline of recurring revenue from the leasing segment.

Detailed definition

This metric forecasts the rental income expected to be generated from operating leases in a future fiscal year. Unlike f...

Peer comparison

Commonly reported in the maturity and future income disclosures of banks with significant operating lease portfolios.

Metric ID: operating_lease_income_2025_lessor

Historical Data

8 periods
 Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$1.70M$1.70M$2.70M$3.50M$3.50M$3.50M$3.50M$3.50M
QoQ Change+0.0%+58.8%+29.6%+0.0%+0.0%+0.0%+0.0%
YoY Change+105.9%+105.9%+29.6%+0.0%+0.0%
Range$1.70M$3.50M
CAGR+51.1%
Avg YoY Growth+48.3%
Median YoY Growth+29.6%
Current Streak7+ quarters growth

Frequently Asked Questions

What is Neurocrine Biosciences's operating lease income - 2025 (lessor)?
Neurocrine Biosciences (NBIX) reported operating lease income - 2025 (lessor) of $3.50M in Q1 2026.
How has Neurocrine Biosciences's operating lease income - 2025 (lessor) changed year-over-year?
Neurocrine Biosciences's operating lease income - 2025 (lessor) decreased by 0.0% year-over-year, from $3.50M to $3.50M.
What does operating lease income - 2025 (lessor) mean?
The projected rental income the bank expects to earn from operating leases in the specified future year.